Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-26 · accession 0001209191-21-053710 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-27 | 2021-08-26+ | BCYC | Kalowski Lee | Pres, CFO | S - Sale+OE | $35.14 | -8,500 | 0 | -100% | -$298.7K |
| DM | 2021-08-27 | 2021-08-26+ | BCYC | Kalowski Lee | Pres, CFO | M - OptEx | $8.73 | +8,500 | 550 | New | +$74.2K |
| DM | 2021-08-27 | 2021-08-26+ | BCYC | Kalowski Lee | Pres, CFO | M - OptEx | $0.00 | -8,500 | 13.7K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-26 | S | D | 550 | $35.04 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). |
| 2 | Common | Ordinary Shares | 2021-08-27 | M | A | 7,950 | $8.73 | 7,950 | D | — | — | (F4) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021. |
| 3 | Common | Ordinary Shares | 2021-08-27 | S | D | 7,950 | $35.15 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.18 inclusive. |
| 4 | Common | Ordinary Shares | 2021-08-26 | M | A | 550 | $8.76 | 550 | D | — | — | (F2) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-27 | M | D | 7,950 | $0.00 | 5,768 | D | $8.73 · — to 2029-03-07 | 7,950 Ordinary Shares | (F4) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021. (F6) 25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-26 | M | D | 550 | $0.00 | 13,718 | D | $8.76 · — to 2029-03-07 | 550 Ordinary Shares | (F2) This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021. (F6) 25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments. |